Silence Therapeutics (SLN) Amortizatization of Intangibles (2024 - 2026)
Silence Therapeutics (SLN) reported Amortizatization of Intangibles of $34000.0 for Q1 2026, down 47.69% on a YoY basis from $65000.0 in Q1 2025, and down 5.56% sequentially from $36000.0 in Q4 2025.
Silence Therapeutics (SLN) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Amortizatization of Intangibles data on file, last reported at $34000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 47.69% year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $212000.0 (down 17.83% YoY), and the FY2025 full-year result was $243000.0, down 5.45% from the prior year.
- Amortizatization of Intangibles fell to $34000.0 in Q1 2026, from $36000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $75000.0 in Q3 2025 to a low of $34000.0 in Q1 2026.
- A 3-year average of $59333.3 and a median of $64000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles increased 15.38% in 2025 and sank 47.69% in 2026, its largest moves.
- Tracing SLN's Amortizatization of Intangibles over 3 years: stood at $64000.0 in 2024, then slumped by 43.75% to $36000.0 in 2025, then retreated by 5.56% to $34000.0 in 2026.
- Business Quant data shows SLN's Amortizatization of Intangibles at $34000.0 in Q1 2026, $36000.0 in Q4 2025, and $75000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Silence Therapeutics | 1.70 Bn | 1.56 Bn | 411,000.00 | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |